Log In
BCIQ
Print this Print this
 

TP-452

  Manage Alerts
Collapse Summary General Information
Company Thetis Pharmaceuticals LLC
DescriptionIonic derivative of n-3 docosapentaenoic acid (DPA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today